For informational purposes only — not a substitute for professional medical advice. Read disclaimer
Parkinsons.org
Last updated: March 2026

Medical Information Notice

This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or qualified healthcare provider. Read full disclaimer

Pain

Overview

Category: Non-motor symptom (Sensory)

Prevalence: Up to 85%

Detailed Information

Pain in PD can be categorized into five types: (1) musculoskeletal -- aching in muscles and joints from rigidity and postural abnormalities, the most common type; (2) dystonic -- sustained painful muscle contractions, especially morning foot dystonia before the first medication dose; (3) central or neuropathic -- burning, tingling, or bizarre painful sensations from CNS changes, not following a peripheral nerve distribution; (4) radicular -- nerve root pain from spinal stenosis or disc disease worsened by PD postural changes; (5) akathitic -- an inner restlessness and uncomfortable urge to move.

Pain often fluctuates with medication cycles and may be the presenting symptom before motor signs are recognized. The 'shoulder syndrome' -- unexplained shoulder pain and stiffness initially misdiagnosed as frozen shoulder, arthritis, or rotator cuff pathology -- is a well-described early presentation of PD. Recognizing pain as a PD symptom rather than an independent condition is essential for appropriate treatment.

Pathophysiology: Why This Happens

Pain processing in PD is altered at multiple levels of the nervous system. Central pain thresholds are reduced in PD, meaning patients perceive pain more intensely than healthy controls. Functional neuroimaging studies show altered activation of pain processing regions (thalamus, insula, anterior cingulate cortex) in PD, even in the absence of painful stimulation.

Dopamine plays a modulatory role in pain processing through the descending pain inhibition system. Degeneration of dopaminergic projections to the spinal cord and brainstem pain-modulating centers reduces the brain's natural pain-suppressing mechanisms. This explains why pain often improves with dopaminergic medication and worsens during off-periods.

Musculoskeletal pain results from chronic abnormal muscle activation patterns due to rigidity, including co-contraction of agonist-antagonist muscle pairs, sustained postural abnormalities, and reduced range of motion. Dystonic pain arises from sustained involuntary muscle contractions, particularly during off-medication periods. Central neuropathic pain reflects direct neurodegeneration in somatosensory pathways. The serotonergic and noradrenergic systems, which contribute to descending pain modulation, are affected early in PD.

Prevalence and Demographics

Pain affects 67-85% of PD patients across studies, making it one of the most common non-motor symptoms. In approximately 5-10% of patients, pain is the first symptom of PD, presenting before motor features are recognized. Musculoskeletal pain is the most prevalent subtype (40-70%), followed by dystonic pain (15-40%), central/neuropathic pain (10-25%), and radicular pain (5-20%).

Pain is significantly more prevalent and severe in PD than in age-matched controls. Women with PD report higher pain prevalence and severity than men. Pain severity correlates with depression, anxiety, sleep disturbance, and reduced quality of life. Patients with motor fluctuations are particularly susceptible to pain fluctuations, with off-period pain being a major contributor to off-period disability.

Differential Diagnosis

Several other conditions can cause similar symptoms. A thorough medical evaluation is essential to distinguish Parkinson's-related pain from other causes:

The key diagnostic challenge is recognizing when pain is a PD symptom rather than an independent condition. The 'shoulder syndrome' is frequently misdiagnosed as rotator cuff disease, adhesive capsulitis, or cervical radiculopathy, leading to unnecessary orthopedic referrals and even surgery. The clue to PD-related shoulder pain is its association with ipsilateral limb rigidity and its improvement with dopaminergic medication.

Central pain in PD must be distinguished from peripheral neuropathy (common in elderly patients, particularly with diabetes), fibromyalgia, and medication-related neuropathy. Dystonic pain should be distinguished from muscle cramps due to dehydration or electrolyte imbalance. Radicular pain from spinal stenosis is common in the PD age group and may coexist with PD-related pain.

The temporal relationship with medication cycles is the most useful diagnostic tool: pain that consistently worsens during off-periods and improves during on-periods is likely PD-related and will respond to optimization of dopaminergic therapy.

How This Symptom Changes by Stage

Pain can present at any disease stage. In the prodromal phase and early stages (1-2), shoulder pain, neck stiffness, and vague musculoskeletal discomfort may precede or accompany the earliest motor symptoms. These complaints are often initially attributed to aging or orthopedic conditions.

At stages 2-3, pain patterns become more clearly related to PD. Morning foot dystonia (painful cramping and curling of the toes upon waking, before the first medication dose) is one of the most characteristic PD pain experiences. Off-period pain fluctuations become apparent in patients with wearing-off motor fluctuations.

In stages 4-5, pain can be severe and multifactorial. Chronic postural abnormalities cause musculoskeletal pain. Immobility leads to contractures and pressure-related pain. Central neuropathic pain may intensify. The combination of severe pain with limited communication ability in advanced disease can lead to significant undertreatment.

Stage-by-Stage Quick Reference

A summary of how pain typically presents at each Hoehn & Yahr stage:

Stage 1
May be present
Stage 2
Often increasing
Stage 3
Frequently significant
Stage 4
Can be severe
Stage 5
Often debilitating

Management Strategies

Optimizing dopaminergic medication is the first-line approach for PD-related pain, particularly pain that fluctuates with medication cycles. Strategies to reduce off-time -- extended-release levodopa, COMT inhibitors, subcutaneous levodopa infusion -- can substantially reduce off-period pain. For morning dystonia specifically, a bedtime dose of controlled-release levodopa or an early morning fast-acting levodopa formulation may provide relief.

Musculoskeletal pain management includes physical therapy for stretching and strengthening, heat or cold therapy, massage, and aquatic therapy. NSAIDs and acetaminophen may provide symptomatic relief. For persistent dystonic pain, botulinum toxin injection into the affected muscles is effective.

Central neuropathic pain may respond to duloxetine (an SNRI that enhances descending pain inhibition), gabapentin, or pregabalin. Opioids should be used cautiously due to sedation, constipation, and cognitive effects. Cannabis-based therapies are under investigation but lack robust evidence in PD pain specifically.

Deep brain stimulation has been shown to improve pain in PD, likely through restoration of central pain modulation pathways. Multidisciplinary pain management involving neurology, physical therapy, and pain medicine is recommended for complex or refractory cases.

Practical Tips

  • Optimize dopaminergic medication timing
  • Stretching and physical therapy for musculoskeletal pain
  • Heat or cold therapy for localized pain
  • Discuss pain management options with neurologist
  • Consider duloxetine for central neuropathic pain

When to See a Doctor

If pain is severe, interferes with sleep or daily activities, or is not controlled by current management strategies.

The Bigger Picture

Pain in PD is a prime example of a symptom that falls through the cracks of medical specialization. Neurologists may not address it because it seems orthopedic; orthopedists may not recognize it because it does not fit typical musculoskeletal patterns; primary care physicians may attribute it to aging. The result is that PD patients endure unnecessary pain that is often quite treatable.

The single most useful clinical question for PD-related pain is: 'Does it get better when your PD medications are working well?' A positive answer strongly suggests PD-related pain that will respond to dopaminergic optimization. This simple question should be asked of every PD patient who reports pain, before embarking on expensive imaging or specialist referrals for other causes.

Sources

  1. [1]Broen MPG, et al. Prevalence of pain in Parkinson disease: a systematic review using the modified QUADAS tool. Mov Disord. 2012;27(4):480-484
  2. [2]Ford B. Pain in Parkinson disease. Mov Disord. 2010;25(Suppl 1):S98-S103
  3. [3]Mylius V, et al. Pain sensitivity and clinical progression in Parkinson disease. Mov Disord. 2011;26(12):2220-2225
  4. [4]Defazio G, et al. The epidemiology of pain in Parkinson disease. J Neural Transm. 2013;120(4):583-586
  5. [5]Fil A, et al. Pain in Parkinson disease: a review of the literature. Parkinsonism Relat Disord. 2013;19(3):285-294
  6. [6]Wasner G, Deuschl G. Pains in Parkinson disease -- many syndromes under one umbrella. Nat Rev Neurol. 2012;8(5):284-294

Share this article

Related Articles